-
1
Study uncovers diversity in trabecular meshwork cells.
-
2
TM3 cells show mitochondrial dysfunction linked to glaucoma.
-
3
Vitamin B3 (nicotinamide) may lower intraocular pressure.
-
4
Potential dual benefits of nicotinamide for TM cells and optic nerve health.
-
5
Future research will compare mouse TM cells with human counterparts.
Original Source(s)
Targeting Trabecular Meshwork Metabolism
Study suggests potential new vitamin B3 treatment for glaucoma protection
March 5, 2026
-
5 min
Related Content
SEE Program Strengthens Adherence
Personalized glaucoma coaching program boosts medication adherence and reduces stress in randomized trial
by Alun Evans
March 4, 2026
-
3 min
Fellow Eyes Reveal Angle Closure Clues
The “quiet” fellow eye in primary angle-closure glaucoma may not be so quiet…
February 12, 2026
-
2 min
